Belvedere Trading
XENT

Belvedere Trading’s Intersect ENT, Inc XENT Stock Holding History

Belvedere Trading’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,784
Closed -$58K – 488
2021
Q1 		$58K Buy
+2,784
New +$64.2K ﹤0.01% 228

Other funds holding XENT

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Belvedere Trading's XENT Position: Q2 2021 in Review

Belvedere Trading sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 2,784 shares — an estimated $58K sold.

Belvedere Trading first reported a position in XENT in Q1 2021 and held it in 1 quarter. The position peaked at $58K in Q1 2021. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.

  • Belvedere Trading reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
  • Belvedere Trading sold 2,784 Intersect ENT, Inc shares in Q2 2021, an estimated $58K.
  • Belvedere Trading first reported a position in Intersect ENT, Inc in Q1 2021 and held it in 1 quarter.
  • Belvedere Trading's Intersect ENT, Inc position peaked at $58K in Q1 2021.
  • 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.

Based on Belvedere Trading's 13F filing for Q2 2021, filed 23 Jul 2021.